SciELO - Scientific Electronic Library Online

 
vol.14 issue4Multilocular thymic cyst. About a caseErythroderma and myeloma. Case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Acta Médica del Centro

On-line version ISSN 2709-7927

Abstract

PEREZ FLEITES, Damarys; BETANCOURT PEREZ, Amelia  and  MARTIN POZO, Yordan. High risk basal cell carcinoma, response to combined HeberFeron treatment and surface radiotherapy. Presentation of a case. Acta méd centro [online]. 2020, vol.14, n.4, pp. 569-575.  Epub Dec 31, 2020. ISSN 2709-7927.

Introduction:

basal cell carcinoma is a malignant tumor of cutaneous location and is the most frequent in humans, especially in the white race. When it appears in the periocular region it is considered to be of high risk due to the possibility of invasion into adjacent and underlying structures.

Case report:

male patient, skin phototype II, who came to the clinic because of the presence of a tumor lesion of 5X2.5cm in diameter, located in the left temple, involving the external angle of the eye. Clinical and histological diagnosis was made and treatment with HeberFeron was decided due to the location and size of the lesion. A first cycle of treatment was performed and a partial response was obtained with a reduction of the lesion to 2x2cm, and then a second cycle of treatment was decided. It was maintained as a stable disease, so treatment with superficial radiotherapy was indicated; it presented complete disease response, clinical and dermatoscopic.

Conclusions:

HeberFeron therapy was effective in reducing the lesion and, combined with superficial radiotherapy, achieved a complete clinical response and excellent aesthetic results.

Keywords : basal cell carcinoma; HeberFeron; surface radiotherapy; combined treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )